Den enes snor blir den andres bot

Snortransplantation – ordet ger rysningar. Nu presenteras en studie där skånska patienter med kronisk tjock snuva, förbättrades efter att ha använt nässprej inn...

Obesity-drug pioneers win Lasker Award

This year’s Lasker Prize in Clinical Research has been awarded to three researchers for their discoveries in GLP-1-based drugs that, according to the jury, “hav...

Rise and Scantox cease conducting animal testing in Stockholm

Access to in vivo toxicology services is significantly decreasing in the Stockholm area as Rise shuts down animal testing and Scantox reorganizes. ”The costs ar...

Stockholm and Uppsala jointly form a life science cluster

Stockholm and Uppsala are strengthening cooperation in medical research and biotech.

Enhance your expertise with your measuring software

Discover the training options in our ZEISS Metrology Portal.

Spatial Biology Studies in Lung Tissue using Spectral Microscopy

Spectral imaging with the ZEISS LSM 980 laser scanning confocal enables more complex studies of cell-cell interactions and locations in immunology research.

Webinar: Automate your processes

Free ZEISS webinar on January 30th, 2025.

Italian pharmaceutical company buys rights to immunotherapy from Sanofi

Italy's Recordati buys the rights to a treatment for the rare autoimmune disease cold agglutinin disease (CAD).

Quality Assurance for the Highest Medical Standards

Metrology Solutions for Medical Components.

ZEISS Hosts an exceptional Global Conference on Innovation and Production in Berlin

More than 50 distinguished speakers from leading manufacturing companies.

Several departures at the top at Nykode

Members of both the management and the board are leaving the Norwegian biotech company Nykode.

”The importance of stratification in a statistician’s August kitchen”

Ingrid Lönnstedt writes about an experiment of her own at home and about what lessons can be learned from it, in a science column.

Inget statligt stöd för fetmaläkemedel – aktien för läkemedelsjättar pressas

Trump-administrationen slopar Bidens förslag om att om att inkludera fetmaläkemedel i sjukförsäkringen Medicare. Det innebär ett bakslag för Novo Nordisk och El...

Compact and leak-tight powerhouse

Media-separated solenoid valve VYKA from Festo is virtually leak-free

From lab to patient – the art of developing new antibody therapies

For 25 years, Danish company Genmab has been developing antibodies and has managed to get several drugs all the way to the patient. Esther Breij has been along ...

Svensk toppforskare inom alzheimer värvas av Eli Lilly

En av Sveriges ledande alzheimerforskare, Oskar Hansson, rekryteras av läkemedelsjätten Eli Lilly och kommer att ta klivet över till USA.

Trumps nya FDA-chef varnar för "massiv övermedicinering"

Donald Trump har nominerat kirurgen och författaren Marty Makary till ny chef för den amerikanska läkemedelsmyndigheten FDA, som enligt den tillträdande preside...

Marie Gårdmark: “What to expect from Trump’s second term?”

One may complain about the complex multinational system in EU, but it gives us some predictability that cannot be easily overturned by different member states p...

Conference recordings now available

Don't miss out on insights from leading experts.

From powder to implant

Quality assurance for additively manufactured implants.

Pila Pharma tar in 20 miljoner kronor – inleder ”dedikerat fetmaspår”

Malmöbolaget Pila Pharma utvecklar ett nytt, oralt läkemedel för behandling av typ 2-diabetes. Ett nytt kapitaltillskott ska användas för att initiera studier o...

Scientific Solutions

Her company is developing a new tablet form obesity drug

Obesity and diabetes are the primary targets of a new tablet treatment under development by Malmö-based Pila Pharma. The company’s ambition is to take on the bi...

Cytel Sweden